Viewing Study NCT06582771



Ignite Creation Date: 2024-10-26 @ 3:39 PM
Last Modification Date: 2024-10-26 @ 3:39 PM
Study NCT ID: NCT06582771
Status: RECRUITING
Last Update Posted: None
First Post: 2024-08-30

Brief Title: A Study of Sotorasib in People With Non-Small Cell Lung Cancer
Sponsor: None
Organization: None

Study Overview

Official Title: A Phase 2 Study of First-line Sotorasib for Patients With Advanced KRAS G12C-mutant Non-small Cell Lung Cancer
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The researchers are doing this study to see if sotorasib is a safe and effective treatment for people with advanced non-small cell lung cancer NSCLC with a KRAS G12C mutation who have not received treatment for their cancer since it became advanced Participants have not received a first-line therapy since their cancer became advanced
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None